PATRICK EVANS: Open Payments
NPI 1629547484 · PFLUGERVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,131 in 106 payments from 20 companies in 2025. Trend: 2023 $907 · 2024 $804 · 2025 $2,131
Food & beverage: $2,131
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $551 |
| Novartis Pharmaceuticals Corporation | 13 | $350 |
| Botanix SB Inc | 10 | $149 |
| Lilly USA, LLC | 5 | $118 |
| Amgen Inc. | 6 | $104 |
| UCB, Inc. | 3 | $95 |
| GENZYME CORPORATION | 4 | $88 |
| Arcutis Biotherapeutics, Inc. | 4 | $84 |
| Incyte Corporation | 3 | $77 |
| Regeneron Healthcare Solutions, Inc. | 4 | $73 |
Products named: SKYRIZI, RINVOQ, COSENTYX, SOFDRA, DUPIXENT, OTEZLA, TALTZ, Bimzelx.
Industry payments across TX — which companies pay providers there.
